FStar Therapeutics - Delisted Stock
FStar Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day FStar Therapeutics was actively traded.
Valuation
Check how we calculate scores
FStar Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. FStar Therapeutics market risk premium is the additional return an investor will receive from holding FStar Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in FStar Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although FStar Therapeutics' alpha and beta are two of the key measurements used to evaluate FStar Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.89 | |||
| Semi Deviation | 8.48 | |||
| Standard Deviation | 11.36 | |||
| Variance | 129.12 |
FStar Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with FStar Therapeutics stock to make a market-neutral strategy. Peer analysis of FStar Therapeutics could also be used in its relative valuation, which is a method of valuing FStar Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
FStar Therapeutics Corporate Management
Elected by the shareholders, the FStar Therapeutics' board of directors comprises two types of representatives: FStar Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of FStar. The board's role is to monitor FStar Therapeutics' management team and ensure that shareholders' interests are well served. FStar Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, FStar Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lindsey Trickett | VP Communications | Profile | |
| Darlene MBA | Treasurer CFO | Profile | |
| Neil Brewis | Chief Officer | Profile | |
| Eliot MBA | CEO Pres | Profile | |
| James MPhil | Chief Officer | Profile | |
| Louis MD | Chief Officer | Profile |
Still Interested in FStar Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in FStar Stock
If you are still planning to invest in FStar Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FStar Therapeutics' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |